Hyperpituitarism

Disease of the glandular, anterior portion of the pituitary (PITUITARY GLAND, ANTERIOR) resulting in hypersecretion of ADENOHYPOPHYSEAL HORMONES such as GROWTH HORMONE; PROLACTIN; THYROTROPIN; LUTEINIZING HORMONE; FOLLICLE STIMULATING HORMONE ; and ADRENOCORTICOTROPIC HORMONE. Hyperpituitarism usually is caused by a functional ADENOMA.

Also Known As:

Pituitary FSH Hypersecretion; Pituitary LH Hypersecretion; Pituitary TSH Hypersecretion; FSH Hypersecretion, Pituitary; Hypersecretion, Pituitary FSH; Hypersecretion, Pituitary LH; Hypersecretion, Pituitary TSH; LH Hypersecretion, Pituitary; TSH Hypersecretion, Pituitary; Follicle Stimulating Hormone, Inappropriate Secretion; Inappropriate FSH Secretion Syndrome; Inappropriate Follicle Stimulating Hormone Secretion; Inappropriate LH Secretion Syndrome; Inappropriate Luteinizing Hormone Secretion; Inappropriate TSH Secretion Syndrome; Inappropriate Thyroid Stimulating Hormone Secretion; Luteinizing Hormone, Inappropriate Secretion; Thyroid Stimulating Hormone, Inappropriate Secretion

Networked: 15 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Hyperthyroidism
2.	Pituitary Neoplasms (Pituitary Adenoma)
3.	Graves Disease (Basedow Disease)
4.	Primary Hyperparathyroidism
5.	Pituitary ACTH Hypersecretion

Experts

1.	Deai, Masahito: 1 article (04/2020)
2.	Kojima, Ryotaro: 1 article (04/2020)
3.	Mogi, Chihiro: 1 article (04/2020)
4.	Murakami, Syo: 1 article (04/2020)
5.	Musha, Shiori: 1 article (04/2020)
6.	Okajima, Fumikazu: 1 article (04/2020)
7.	Saso, Naoshi: 1 article (04/2020)
8.	Sato, Koichi: 1 article (04/2020)
9.	Tomura, Hideaki: 1 article (04/2020)
10.	Yoshida, Saishu: 1 article (04/2020)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Hyperpituitarism:

1.	Thyroid HormonesIBA 07/01/1990 - "generalized thyroid hormone resistance (GRTH), selective pituitary resistance [non-neoplastic IST (nnIST)], and tumoral pituitary TSH hypersecretion [neoplastic IST (nIST)], mainly rests on clinical observation, skull imaging, and measurement of several parameters assessing peripheral thyroid hormone effects. " 12/01/1986 - "A parallelism exists between thyroid hypertrophy and pituitary TSH hypersecretion, due to a decrease in thyroid hormone levels." 01/01/1992 - "Primary therapy for hyperthyroidism due to selective pituitary resistance to thyroid hormone is aimed at suppression of pituitary TSH hypersecretion. "
2.	Hormones (Hormone)IBA 04/10/2020 - "Hormone-secreting pituitary adenomas show unregulated hormonal hypersecretion and cause hyperpituitarism. " 06/16/1951 - "[Basedow's disease from hyperpituitarism; importance of the biologic determination of the thyrotropic hormone for diagnosis; remarkable effectiveness of pituitary inhibiting therapeutic agents]." 11/01/1983 - "For patients with pituitary adenomas and clinical features of hyperpituitarism, such as hyperprolactinaemia, Cushing's disease or acromegaly, the initial tests should be directed at the hormone whose excess is suspected. "
3.	Dehydroepiandrosterone SulfateIBA 04/01/1989 - "Aggravation of inappropriate luteinizing hormone secretion by bromocriptine in polycystic ovary syndrome with elevated serum dehydroepiandrosterone sulfate."
4.	Octreotide (Sandostatin)FDA LinkGeneric 08/01/1998 - "In the management of inappropriate TSH secretion syndrome hypophysectomy, irradiation and long-acting somatostatin analog octreotide are applied."
5.	Vasopressins (Vasopressin)IBA 09/01/2012 - "These disorders include hypopituitarism, growth failure, diencephalic syndrome, delayed puberty, precocious puberty, diabetes insipidus, syndrome of inappropriate antidiuretic hormone (SIADH) secretion, and hyperpituitarism. "
6.	Triiodothyronine (Liothyronine)FDA LinkGeneric 06/01/1955 - "Further evidence that hyperthyroidism (Graves' disease) is not hyperpituitarism: effects of triiodothyronine and sodium iodide."
7.	Thyroxine (Levothyroxine)FDA LinkGeneric 06/01/2000 - "Increased levothyroxine requirements presenting as "inappropriate" TSH secretion syndrome in a patient with nephrotic syndrome."
8.	Growth Hormone (Somatotropin)IBA 01/01/1997 - "Secondary OP, mostly generalized, is diagnosed in the course of such hormonal disturbances as: primary hyperparathyroidism, hyperthyroidism, hyperadrenalocorticalism, hyperpituitarism (with excess of growth hormone) and in hypogonadism. "
9.	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 08/01/1998 - "In the management of inappropriate TSH secretion syndrome hypophysectomy, irradiation and long-acting somatostatin analog octreotide are applied."
10.	Sodium IodideIBA 06/01/1955 - "Further evidence that hyperthyroidism (Graves' disease) is not hyperpituitarism: effects of triiodothyronine and sodium iodide."

Therapies and Procedures

1.	Therapeutics 01/01/1992 - "Primary therapy for hyperthyroidism due to selective pituitary resistance to thyroid hormone is aimed at suppression of pituitary TSH hypersecretion. "
2.	Hypophysectomy 08/01/1998 - "In the management of inappropriate TSH secretion syndrome hypophysectomy, irradiation and long-acting somatostatin analog octreotide are applied."